Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences and challenges of people with multiple sclerosis and low attendance to clinical follow-up: a qualitative study.

BMC neurology·2025
Same author

The effect of 2 different premilking stimulation regimens, with and without a latency period, on teat tissue condition and milking performance in Holstein dairy cows.

Journal of dairy science·2023
Same author

Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals.

Epidemiology and psychiatric sciences·2022
Same author

Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls.

HIV medicine·2020
Same author

Contribution of remnant cholesterol to cardiovascular risk.

Journal of internal medicine·2020
Same author

Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Related Experiment Video

Updated: May 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.

M Thomsen1, B G Nordestgaard, A A Sethi

  • 1Dept of Clinical Biochemistry, Herlev Hospital, Herlev, Denmark.

The European Respiratory Journal
|November 15, 2011
PubMed
Summary

The ADRB2 Thr164Ile gene variant is linked to poorer lung function and a higher risk of chronic obstructive pulmonary disease (COPD). This finding is based on genetic analysis of over 60,000 individuals, highlighting a significant association in the general population.

Related Experiment Videos

Last Updated: May 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

  • Genetics and Respiratory Medicine
  • Pharmacogenomics of Adrenergic Receptors

Background:

  • The beta-2 adrenergic receptor (ADRB2) plays a crucial role in regulating airway smooth muscle tone.
  • Genetic variations in the ADRB2 gene may influence lung function and susceptibility to respiratory diseases.

Purpose of the Study:

  • To investigate the association between three functional polymorphisms in the ADRB2 gene (Thr164Ile, Gly16Arg, and Gln27Glu) and lung function, asthma, and COPD.
  • Specifically, to examine the impact of the Thr164Ile polymorphism on lung function parameters and COPD risk.

Main Methods:

  • Genotyping of 8,971 individuals from the Copenhagen City Heart Study for three ADRB2 polymorphisms.
  • Validation genotyping of 53,777 individuals from the Copenhagen General Population Study for the Thr164Ile polymorphism.
  • Statistical analysis to assess the association between genotypes and lung function (FEV(1)% predicted, FEV(1)/FVC) and COPD prevalence.

Main Results:

  • The ADRB2 Thr164Ile genotype was significantly associated with reduced FEV(1)% predicted and FEV(1)/FVC in both study cohorts.
  • Heterozygotes for Thr164Ile showed a 3% and 2% reduction in FEV(1)% pred and FEV(1)/FVC, respectively, in the Copenhagen City Heart Study.
  • In the Copenhagen General Population Study, Thr164Ile homozygotes and heterozygotes exhibited reduced FEV(1)% pred and FEV(1)/FVC.
  • An increased odds ratio for COPD was observed in Thr164Ile heterozygotes (1.46) in the Copenhagen City Heart Study and in homozygotes (4.53) in the Copenhagen General Population Study.

Conclusions:

  • The ADRB2 Thr164Ile polymorphism is associated with diminished lung function.
  • This genetic variant is linked to an increased risk of developing chronic obstructive pulmonary disease (COPD) in the general population.
  • These findings underscore the role of ADRB2 genetic variations in respiratory health and disease susceptibility.